|
|
| | SI-2 Hydrochloride Basic information |
| Product Name: | SI-2 Hydrochloride | | Synonyms: | SI-2 Hydrochloride;EPH 116 hydrochloride;1-Methyl-2-(2-(1-(pyridin-2-yl)ethylidene)hydrazineyl)-1H-benzo[d]imidazole hydrochloride | | CAS: | 1992052-49-9 | | MF: | C15H16ClN5 | | MW: | 301.78 | | EINECS: | | | Product Categories: | | | Mol File: | 1992052-49-9.mol |  |
| | SI-2 Hydrochloride Chemical Properties |
| form | Solid | | color | Pink to red |
| | SI-2 Hydrochloride Usage And Synthesis |
| Uses | SI-2 Hydrochloride is a useful intermediate. | | in vivo | SI-2 causes minimal acute cardiotoxicity based on a hERG channel blocking assay and an unappreciable chronic toxicity to major organs based on histological analyses[1].
SI-2 is a drug-like molecule and meets all of the criteria of Lipinski’s rule[1].
| Animal Model: | MDA-MB-468 breast cancer mouse model[1].
| | Dosage: | 2 mg/kg. | | Administration: | Twice daily for 5 weeks (Vehicle, PBS). | | Result: | Significantly inhibit tumor growth.
SRC-3 levels in SI-2–treated tumor tissues were significantly lower than the PBS treated control group.
|
| Animal Model: | CD1 mice[1]. | | Dosage: | 20 mg/kg (Pharmacokinetic Analysis). | | Administration: | Intraperitoneal administration once. | | Result: | T1/2 = 1 h, Cmax of 3.0 μM, and the time to reach the maximum plasma concentration tmax of 0.25 h.
SI-2 only degrades slightly (less than 5%) at pH 1.6 and 3.0 within 6 h, and is stable in buffers with pH ≥ 5.
|
|
| | SI-2 Hydrochloride Preparation Products And Raw materials |
|